This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Scheaffer, A.N. Proposed usage of animal tissue culture terms (revised 1978). Usage of vertebrate cell, tissue and organ culture terminology. In Vitro, 1979; 15(9): 649–653.
Brenneman, D.E., et al. Protective peptides that are orally active and mechanistically nonchiral. J. Pharmacol. Exp. Ther., 2004; 309(3): 1190–1197.
Pilzer, I., and Gozes, I. A splice variant to PACAP receptor that is involved in spermatogenesis is expressed in astrocytes. Ann. NY Acad. Sci., 2006; 1070: 484–490.
Romijn, H.J., et al. Nerve outgrowth, synaptogenesis and bioelectric activity in fetal rat cerebral cortex tissue cultured in serum-free, chemically defined medium. Brain Res., 1981; 254(4): 583–589.
Brenneman, D.E., et al. Complex array of cytokines released by vasoactive intestinal peptide. Neuropeptides, 2003; 37(2): 111–119.
Dangoor, D., et al. Novel extended and branched N-terminal analogs of VIP. Regul. Pept., 2006; 137(1–2): 42–49.
Offen, D., et al. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: Relevance to neuroprotection in Parkinson’s disease. Brain Res., 2000; 854(1–2): 257–262.
Davidson, A., Moody, T.W., and Gozes, I. Regulation of VIP gene expression in general. Human lung cancer cells in particular. J. Mol. Neurosci., 1996; 76(2): 99–110.
Moody, T.W., et al. (N-stearyl, norleucine17)VIP hybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist. J. Mol. Neurosci., 2002; 18(1–2): 29–35.
Gozes, Y., et al. Conditioned media from activated lymphocytes maintain sympathetic neurons in culture. Brain Res., 1982; 282(1): 93–97.
Brenneman, D.E., and Gozes, I. A femtomolar-acting neuroprotective peptide. J. Clin. Invest., 1996; 97(10): 2299–2307.
Bassan, M., et al. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem., 1999; 72(3): 1283–1293.
Gozes, I., et al. NAP: Research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS Drug Rev., 2005; 11(4): 353–368.
Gozes, I., et al. Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA, 1996; 93(1): 427–432.
Visochek, L., et al. PolyADP-ribosylation is involved in neurotrophic activity. J. Neurosci., 2005; 25(32): 7420–7428.
Divinski, I., et al. Peptide neuroprotection through specific interaction with brain tubulin. J. Neurochem., 2006; 98(3): 973–984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc.
About this protocol
Cite this protocol
Divinski, I., Pilzer, I., Gozes, I. (2008). Primary Cell Cultures and Cell Lines. In: Gozes, I. (eds) Neuropeptide Techniques. Neuromethods, vol 39. Humana Press. https://doi.org/10.1007/978-1-60327-099-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-60327-099-1_3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-468-5
Online ISBN: 978-1-60327-099-1
eBook Packages: Springer Protocols